Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Real Regulatory News (SREI)

Share Price Information for Schroder Real (SREI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.10
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.50 (1.147%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 44.10
SREI Live PriceLast checked at -
Schroder Real Estate is an Investment Trust

To provide the shareholders with an attractive level of income, together with the potential for income and capital growth, from investing in a diversified portfolio of UK commercial real estate.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-financing to Reduce Debt Cost and Extend Duration

4 Jul 2018 07:00

Schroder Real Estate Investment Trust Ltd - Re-financing to Reduce Debt Cost and Extend Duration

Schroder Real Estate Investment Trust Ltd - Re-financing to Reduce Debt Cost and Extend Duration

PR Newswire

London, July 3

04 July 2018

Schroder Real Estate Investment Trust Limited("SREIT"/ the "Company" / "Group")

RE-FINANCING COMPLETED TO REDUCE DEBT COST AND EXTEND DURATION

Schroder Real Estate Investment Trust, the actively managed UK-focused REIT, announces that it has completed two refinancings in respect of its £129.6 million term loan with Canada Life and its £20.5 million revolving credit facility (“RCF”) with Royal Bank of Scotland (‘RBS’). These initiatives reduce the Company’s interest costs and extend the overall duration of its debt facilities.

Improved terms with the refinancing and part extension of Canada Life term loan:

The refinancing is in respect of the £25.9 million portion of the loan that was due to expire in April 2023. The maturity of this portion has been extended by five years to be co-terminus with the rest of the loan, due to expire in April 2028 and fixing this interest rate for a further five years to remove the risk of rising interest rates. The fixed interest rate cost has reduced from a 4.77% to 3.09% on this portion of the loan, saving approximately £435,000 of interest per annum. The refinancing has resulted in a negotiated break cost of £2.625 million.

Extension of the revolving credit facility:

The Company has also extended its RCF with RBS and increased the available facility from £20.5 million to £32.5 million, with £20.5 million already drawn. The additional loan amount available provides the Company with greater funding flexibility, to be used for acquisitions or capital expenditure across the portfolio. The RCF is an efficient and flexible source of funding due to the low margin of 1.6% and the ability to be repaid and redrawn as often as required and substitute assets within its security pool. The existing RCF had been due to expire in July 2019, and the new five year loan has a maturity in July 2023. The Company will also extend its interest rate caps in respect of the RCF to align with the new term of the facility and mitigate the potential risk of interest rate increases.

These transactions capitalise on current low interest rates and reposition the balance sheet for a lower cost and longer term. This active management of the balance sheet results in:

Competitive financing terms that lengthen both near-term debt maturity dates by five years, and extend the average weighted debt term from 7.7 years to approximately 9 years. The overall cost of debt reduces from 4.4% to 4.0% assuming the RCF is fully drawn. Over 80 per cent. of the Company’s debt is fixed with the remainder capped. Enlarged RCF provides additional liquidity for acquisitions and capital expenditure, with the ability to efficiently de-gear following asset sales or equity issuance. The Company’s net LTV post the transactions is approximately 26% based on the 31 March 2018 valuation, within the target ratio of 25% to 35%.

The successful refinancing combined with contemplated acquisitions should allow the Board to consider the Company’s ability to progressively increase the level of dividend.

-ENDS-

For further information:

Schroder Real Estate Investment Management Limited: Duncan Owen / Nick Montgomery / Frank Sanderson020 7658 6000
Northern Trust: Fraser Hiddelston01481 745529
FTI Consulting: Dido Laurimore / Richard Gotla020 3727 1000
Date   Source Headline
7th Sep 20226:00 pmRNSTransaction in Own Shares
6th Sep 20226:09 pmRNSTransaction in Own Shares
1st Sep 20225:50 pmRNSTransaction in Own Shares
1st Sep 202210:05 amRNSTotal Voting Rights
31st Aug 20225:37 pmRNSTransaction in Own Shares
30th Aug 20225:15 pmRNSTransaction in Own Shares
18th Aug 20225:13 pmRNSTransaction in Own Shares
16th Aug 20226:13 pmRNSTransaction in Own Shares
16th Aug 20229:27 amRNSTransaction in Own Shares
9th Aug 20225:24 pmRNSTransaction in Own Shares
1st Aug 202210:19 amRNSTotal Voting Rights
29th Jul 20225:46 pmRNSHolding(s) in Company
29th Jul 20223:59 pmRNSInvestor Meet Company Presentation
28th Jul 20226:10 pmRNSTransaction in Own Shares
27th Jul 202211:11 amRNSNAV and Dividend for the quarter to 30 June 2022
27th Jul 20227:01 amRNSShare Buyback Programme
27th Jul 20227:00 amRNSNAV and Dividend for quarter to 30 June 2022
15th Jul 202211:07 amRNSDirector/PDMR Shareholding
30th Jun 20227:00 amRNSDisposal and Asset Management Update
9th Jun 20225:07 pmRNSHolding(s) in Company
8th Jun 20224:29 pmRNSDirector/PDMR Shareholding
7th Jun 20227:02 amRNSAppointment of Priscilla Davies
7th Jun 20227:01 amRNSDividend Declaration
7th Jun 20227:00 amRNSFull Year Results for the year ended 31 March 2022
6th Jun 20223:47 pmRNSHolding(s) in Company
31st May 20227:00 amRNSAcquisition of Manchester city centre asset
26th May 20227:00 amRNSInvestor Presentation
25th May 202210:17 amRNSNotice of Results
19th Apr 20224:00 pmRNSHolding(s) in Company
19th Apr 20223:50 pmRNSHolding(s) in Company
13th Apr 202212:52 pmRNSDirector/PDMR Shareholding
9th Mar 202211:07 amRNSHolding(s) in Company
1st Mar 20227:00 amRNSAnnouncement of NAV and Dividend
23rd Feb 202212:05 pmRNSDirector/PDMR Shareholding
11th Feb 20227:00 amRNS£13m Nottingham Office Disposal
17th Jan 202211:52 amRNSDirector/PDMR Shareholding
6th Dec 20211:07 pmRNSDirector/PDMR Shareholding
23rd Nov 20217:00 amRNSDividend Announcement
23rd Nov 20217:00 amRNSInterim Results for the Period Ended 30 Sept 2021
22nd Nov 20217:00 amRNSIndustrial portfolio acquisition
15th Nov 20217:00 amRNSAsset management update
2nd Nov 202110:49 amRNSNotice of Results
20th Oct 20219:04 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amPRNBoard Succession Planning
1st Oct 20217:00 amPRNChange of Company Secretary and Registered Office
20th Sep 20217:00 amPRNAsset Management and Rent Collection Update
9th Sep 20213:05 pmPRNResults of AGM
5th Aug 20219:55 amPRNDirector/PDMR Shareholding
27th Jul 202111:00 amPRNNotice of AGM
19th Jul 20217:00 amPRNNAV and Dividend for Quarter to 30 June 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.